BCR-ABL1 in leukemia: Disguise master outplays riding shotgun

Leukemia is a many-sided molecular disorder that arises because of over expression of oncogenes, suppression of tumor suppressor genes, and chromosomal translocations. These chromosomal rearrangements are nonetheless among the many determinants that underlie transformation of cells from normal to a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cancer research and therapeutics 2013-01, Vol.9 (1), p.6-10
Hauptverfasser: Rana, Aamir, Ali, Ghulam, Ali, Shaukat, Khan, Ammara, Mansoor, Sajid, Malik, Shazia, Farooqi, Ammad
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10
container_issue 1
container_start_page 6
container_title Journal of cancer research and therapeutics
container_volume 9
creator Rana, Aamir
Ali, Ghulam
Ali, Shaukat
Khan, Ammara
Mansoor, Sajid
Malik, Shazia
Farooqi, Ammad
description Leukemia is a many-sided molecular disorder that arises because of over expression of oncogenes, suppression of tumor suppressor genes, and chromosomal translocations. These chromosomal rearrangements are nonetheless among the many determinants that underlie transformation of cells from normal to a cancerous phenotype and predispose cells to refractoriness against interventions by reduced drug influx and substantial drug efflux. This review unfolds current understanding of BCR-ABL1 (break point cluster region-c-abl oncogene 1, non-receptor tyrosine kinase) signaling with a focus on apoptotic suppressive mechanisms and alternative approaches to chronic myeloid leukemia therapy.
doi_str_mv 10.4103/0973-1482.110339
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1326732619</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A328334772</galeid><sourcerecordid>A328334772</sourcerecordid><originalsourceid>FETCH-LOGICAL-c543a-a360124e610a797ff37525a33b8533d9e7c65735c2f3cc580b42db39c5513fde3</originalsourceid><addsrcrecordid>eNptksFrHCEUxqU0NNu0957KQC-9zFZ94zhT6GGzTdrAQqC0Z3EdZ2rW0a2OLPnv67LZtAmLiKi_7-Pp9xB6R_C8Ihg-4ZZDSaqGzkneQvsCzUjbNmVFoHmJZo_X5-h1jHcYM05p8wqdU2Cc4bqeoS-Xyx_l4nJFCuMKq9NGj0Z-Lr6aOCQTdTHKOOlQ-DRtrbyPRTCdcUMRf_tpSO4NOuuljfrtw3qBfl1f_Vx-L1e3326Wi1WpWAWylFBjQitdEyx5y_seOKNMAqwbBtC1mquacWCK9qAUa_C6ot0aWsUYgb7TcIE-Hny3wf9JOk5iNFFpa6XTPkVBgNY8T9Jm9MMz9M6n4HJ1mao4azjl7B81SKuFcb2fglR7U7EA2kAmOc1UeYIatNNBWu90b_LxE35-gs-jy7-qTgrwQaCCjzHoXmyDGWW4FwSLfcJiH6HYRygOCWfJ-4f3pfWou0fBMdIMrA7AztscXdzYtNNBZHbj_O6JcfmfsajFsRVy5eLYCvAXo92ztQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1347587275</pqid></control><display><type>article</type><title>BCR-ABL1 in leukemia: Disguise master outplays riding shotgun</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Medknow Open Access Journals</source><creator>Rana, Aamir ; Ali, Ghulam ; Ali, Shaukat ; Khan, Ammara ; Mansoor, Sajid ; Malik, Shazia ; Farooqi, Ammad</creator><creatorcontrib>Rana, Aamir ; Ali, Ghulam ; Ali, Shaukat ; Khan, Ammara ; Mansoor, Sajid ; Malik, Shazia ; Farooqi, Ammad</creatorcontrib><description>Leukemia is a many-sided molecular disorder that arises because of over expression of oncogenes, suppression of tumor suppressor genes, and chromosomal translocations. These chromosomal rearrangements are nonetheless among the many determinants that underlie transformation of cells from normal to a cancerous phenotype and predispose cells to refractoriness against interventions by reduced drug influx and substantial drug efflux. This review unfolds current understanding of BCR-ABL1 (break point cluster region-c-abl oncogene 1, non-receptor tyrosine kinase) signaling with a focus on apoptotic suppressive mechanisms and alternative approaches to chronic myeloid leukemia therapy.</description><identifier>ISSN: 0973-1482</identifier><identifier>EISSN: 1998-4138</identifier><identifier>DOI: 10.4103/0973-1482.110339</identifier><identifier>PMID: 23575066</identifier><language>eng</language><publisher>India: Medknow Publications</publisher><subject>Apoptosis ; Care and treatment ; Disease Progression ; Drug Resistance, Neoplasm - genetics ; Fusion Proteins, bcr-abl - genetics ; Fusion Proteins, bcr-abl - metabolism ; Gene expression ; Genetic aspects ; Humans ; Kinases ; Leukemia ; Leukemia - drug therapy ; Leukemia - genetics ; Leukemia - metabolism ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism ; Mutation ; Proteins ; Risk factors ; Signal Transduction</subject><ispartof>Journal of cancer research and therapeutics, 2013-01, Vol.9 (1), p.6-10</ispartof><rights>COPYRIGHT 2013 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt Ltd Jan 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c543a-a360124e610a797ff37525a33b8533d9e7c65735c2f3cc580b42db39c5513fde3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27458,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23575066$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rana, Aamir</creatorcontrib><creatorcontrib>Ali, Ghulam</creatorcontrib><creatorcontrib>Ali, Shaukat</creatorcontrib><creatorcontrib>Khan, Ammara</creatorcontrib><creatorcontrib>Mansoor, Sajid</creatorcontrib><creatorcontrib>Malik, Shazia</creatorcontrib><creatorcontrib>Farooqi, Ammad</creatorcontrib><title>BCR-ABL1 in leukemia: Disguise master outplays riding shotgun</title><title>Journal of cancer research and therapeutics</title><addtitle>J Cancer Res Ther</addtitle><description>Leukemia is a many-sided molecular disorder that arises because of over expression of oncogenes, suppression of tumor suppressor genes, and chromosomal translocations. These chromosomal rearrangements are nonetheless among the many determinants that underlie transformation of cells from normal to a cancerous phenotype and predispose cells to refractoriness against interventions by reduced drug influx and substantial drug efflux. This review unfolds current understanding of BCR-ABL1 (break point cluster region-c-abl oncogene 1, non-receptor tyrosine kinase) signaling with a focus on apoptotic suppressive mechanisms and alternative approaches to chronic myeloid leukemia therapy.</description><subject>Apoptosis</subject><subject>Care and treatment</subject><subject>Disease Progression</subject><subject>Drug Resistance, Neoplasm - genetics</subject><subject>Fusion Proteins, bcr-abl - genetics</subject><subject>Fusion Proteins, bcr-abl - metabolism</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Humans</subject><subject>Kinases</subject><subject>Leukemia</subject><subject>Leukemia - drug therapy</subject><subject>Leukemia - genetics</subject><subject>Leukemia - metabolism</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism</subject><subject>Mutation</subject><subject>Proteins</subject><subject>Risk factors</subject><subject>Signal Transduction</subject><issn>0973-1482</issn><issn>1998-4138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptksFrHCEUxqU0NNu0957KQC-9zFZ94zhT6GGzTdrAQqC0Z3EdZ2rW0a2OLPnv67LZtAmLiKi_7-Pp9xB6R_C8Ihg-4ZZDSaqGzkneQvsCzUjbNmVFoHmJZo_X5-h1jHcYM05p8wqdU2Cc4bqeoS-Xyx_l4nJFCuMKq9NGj0Z-Lr6aOCQTdTHKOOlQ-DRtrbyPRTCdcUMRf_tpSO4NOuuljfrtw3qBfl1f_Vx-L1e3326Wi1WpWAWylFBjQitdEyx5y_seOKNMAqwbBtC1mquacWCK9qAUa_C6ot0aWsUYgb7TcIE-Hny3wf9JOk5iNFFpa6XTPkVBgNY8T9Jm9MMz9M6n4HJ1mao4azjl7B81SKuFcb2fglR7U7EA2kAmOc1UeYIatNNBWu90b_LxE35-gs-jy7-qTgrwQaCCjzHoXmyDGWW4FwSLfcJiH6HYRygOCWfJ-4f3pfWou0fBMdIMrA7AztscXdzYtNNBZHbj_O6JcfmfsajFsRVy5eLYCvAXo92ztQ</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>Rana, Aamir</creator><creator>Ali, Ghulam</creator><creator>Ali, Shaukat</creator><creator>Khan, Ammara</creator><creator>Mansoor, Sajid</creator><creator>Malik, Shazia</creator><creator>Farooqi, Ammad</creator><general>Medknow Publications</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20130101</creationdate><title>BCR-ABL1 in leukemia: Disguise master outplays riding shotgun</title><author>Rana, Aamir ; Ali, Ghulam ; Ali, Shaukat ; Khan, Ammara ; Mansoor, Sajid ; Malik, Shazia ; Farooqi, Ammad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c543a-a360124e610a797ff37525a33b8533d9e7c65735c2f3cc580b42db39c5513fde3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Apoptosis</topic><topic>Care and treatment</topic><topic>Disease Progression</topic><topic>Drug Resistance, Neoplasm - genetics</topic><topic>Fusion Proteins, bcr-abl - genetics</topic><topic>Fusion Proteins, bcr-abl - metabolism</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Humans</topic><topic>Kinases</topic><topic>Leukemia</topic><topic>Leukemia - drug therapy</topic><topic>Leukemia - genetics</topic><topic>Leukemia - metabolism</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism</topic><topic>Mutation</topic><topic>Proteins</topic><topic>Risk factors</topic><topic>Signal Transduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rana, Aamir</creatorcontrib><creatorcontrib>Ali, Ghulam</creatorcontrib><creatorcontrib>Ali, Shaukat</creatorcontrib><creatorcontrib>Khan, Ammara</creatorcontrib><creatorcontrib>Mansoor, Sajid</creatorcontrib><creatorcontrib>Malik, Shazia</creatorcontrib><creatorcontrib>Farooqi, Ammad</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cancer research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rana, Aamir</au><au>Ali, Ghulam</au><au>Ali, Shaukat</au><au>Khan, Ammara</au><au>Mansoor, Sajid</au><au>Malik, Shazia</au><au>Farooqi, Ammad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>BCR-ABL1 in leukemia: Disguise master outplays riding shotgun</atitle><jtitle>Journal of cancer research and therapeutics</jtitle><addtitle>J Cancer Res Ther</addtitle><date>2013-01-01</date><risdate>2013</risdate><volume>9</volume><issue>1</issue><spage>6</spage><epage>10</epage><pages>6-10</pages><issn>0973-1482</issn><eissn>1998-4138</eissn><abstract>Leukemia is a many-sided molecular disorder that arises because of over expression of oncogenes, suppression of tumor suppressor genes, and chromosomal translocations. These chromosomal rearrangements are nonetheless among the many determinants that underlie transformation of cells from normal to a cancerous phenotype and predispose cells to refractoriness against interventions by reduced drug influx and substantial drug efflux. This review unfolds current understanding of BCR-ABL1 (break point cluster region-c-abl oncogene 1, non-receptor tyrosine kinase) signaling with a focus on apoptotic suppressive mechanisms and alternative approaches to chronic myeloid leukemia therapy.</abstract><cop>India</cop><pub>Medknow Publications</pub><pmid>23575066</pmid><doi>10.4103/0973-1482.110339</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0973-1482
ispartof Journal of cancer research and therapeutics, 2013-01, Vol.9 (1), p.6-10
issn 0973-1482
1998-4138
language eng
recordid cdi_proquest_miscellaneous_1326732619
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Medknow Open Access Journals
subjects Apoptosis
Care and treatment
Disease Progression
Drug Resistance, Neoplasm - genetics
Fusion Proteins, bcr-abl - genetics
Fusion Proteins, bcr-abl - metabolism
Gene expression
Genetic aspects
Humans
Kinases
Leukemia
Leukemia - drug therapy
Leukemia - genetics
Leukemia - metabolism
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism
Mutation
Proteins
Risk factors
Signal Transduction
title BCR-ABL1 in leukemia: Disguise master outplays riding shotgun
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A19%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=BCR-ABL1%20in%20leukemia:%20Disguise%20master%20outplays%20riding%20shotgun&rft.jtitle=Journal%20of%20cancer%20research%20and%20therapeutics&rft.au=Rana,%20Aamir&rft.date=2013-01-01&rft.volume=9&rft.issue=1&rft.spage=6&rft.epage=10&rft.pages=6-10&rft.issn=0973-1482&rft.eissn=1998-4138&rft_id=info:doi/10.4103/0973-1482.110339&rft_dat=%3Cgale_proqu%3EA328334772%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1347587275&rft_id=info:pmid/23575066&rft_galeid=A328334772&rfr_iscdi=true